Skip to content Skip to footer
Subscribe Now
Jeremiah Robison, Founder, and CEO of Cionic Shares Insights on the Collaboration with Yves Behar’s fuseproject for the Cionic Neural Sleeve
VIEWPOINTS

Jeremiah Robison, Founder, and CEO of Cionic Shares Insights on the Collaboration with Yves Behar’s fuseproject for the Cionic Neural Sleeve

Shots: Jeremiah spoke about Cionic’s recent collaboration with designer Yves Behar and his design firm, fuseproject to deliver its bionic leg wearable to determine human mobility in real-time He talked about the results from the CIONIC trial and also discussed home usability trials to understand the impact of the Neural Sleeve on mobility over time…
August 24, 2022

Read more

Dr. Vivek Lal, Founder & CEO at ResBiotic Shares Insights from the New Preclinical Data for resB Lung Support Presented at DDW 2022
VIEWPOINTS

Dr. Vivek Lal, Founder & CEO at ResBiotic Shares Insights from the New Preclinical Data for resB Lung Support Presented at DDW 2022

Shots: Dr. Vivek talked about the results from the preclinical study of its probiotic and herbal supplement for lung health in a poster presented at DDW 2022 He also spoke about how resB helps to decrease MMP-9 inflammatory pathway activity, associated with tissue damage and neutrophilic inflammation The interview provides a deep understanding of Resbiotic’s…
August 23, 2022

Read more

Laura Yecies, CEO at Bone Health Technologies Shares Insights on Osteoporosis Prevention Study for Postmenopausal Women With Osteopenia
VIEWPOINTS

Laura Yecies, CEO at Bone Health Technologies Shares Insights on Osteoporosis Prevention Study for Postmenopausal Women With Osteopenia

Shots: Laura spoke about the non-drug intervention study to treat osteopenia in postmenopausal women She also talked about the company’s OsteoBoost technology which is a convenient treatment to improve bone density The interview provides an understanding of the company’s vision to develop new treatment options for osteoporosis and osteopenia Smriti: Brief us about the background behind…
August 17, 2022

Read more

Leonard Glass, Vice President, Global Medical Affairs at Eli Lilly & Co. Shares Insights from Lilly’s Vision on New Stage of Metabolic Science
VIEWPOINTS

Leonard Glass, Vice President, Global Medical Affairs at Eli Lilly & Co. Shares Insights from Lilly’s Vision on New Stage of Metabolic Science

Shots: Leonard spoke about how Lilly is advancing in the field of metabolic disease research (esp. diabetes) He also talked about its lead candidate in type 2 diabetes and also discussed its clinical results in detail The interview summarizes Lilly’s objective to advance new discoveries and redefine diabetes care Smriti: Tell us how Lilly is leading…
August 16, 2022

Read more

PharmaShots Interview Laurent Levy, CEO of Nanobiotix Shares Insights and Clinical Updates on its Nanoparticle Therapy
VIEWPOINTS

PharmaShots Interview: Laurent Levy, CEO of Nanobiotix Shares Insights and Clinical Updates on its Nanoparticle Therapy

Shots:  Laurent spoke about the study design of its nanoparticle therapy to enhance the cancer-killing effect of radiation, which was presented at ASCO 2022 Laurent also highlighted how this nanoparticle therapy can be a potential radio enhancer in various tumor types and across lines of therapy The interview summarizes Nanobiotix’s vision to advance nanoparticles across…
August 10, 2022

Read more

PharmaShots Interview Dr. R. Preston Mason, Consultant at Amarin, Corp. Shares Insights from its in vitro Study Results
VIEWPOINTS

PharmaShots Interview: Dr. R. Preston Mason, Consultant at Amarin, Corp. Shares Insights from its in vitro Study Results

Shots: Dr. Mason spoke about the key findings from their in vitro study demonstrating EPA + statins effects in reduced lipid oxidation, which were presented at the ACC 2022 He also spoke about the study design of the REDUCE-IT trial and its importance in the approval of its candidate in metabolic and cardiovascular diseases The interview summarizes…
August 3, 2022

Read more

PharmaShots Interview Purnanand Sarma, CEO of Immunome, Shares Insights on R&D Update IL-38 Targeting Antibody Treatment for Cancer
VIEWPOINTS

PharmaShots Interview: Purnanand Sarma, CEO of Immunome, Shares Insights on R&D Update IL-38 Targeting Antibody Treatment for Cancer

Shots:  Purnanand spoke about the preclinical results of lead candidate in oncology and how its identifies IL-38 as a target to treat cancer Purnanand also talked about Immunome’s collaboration with Fox Chase Cancer Center for the further development of its prime product The interview gives a understanding of Immunome’s goal of developing therapeutics to treat…
August 2, 2022

Read more

PharmaShots Interview Abdul Mullick, CEO at Kyowa Kirin Shares Insights on the Launch of a Virtual Exhibition to Highlight Issues of Rare Disease, X-linked Hypophosphataemia
VIEWPOINTS

PharmaShots Interview: Abdul Mullick, CEO at Kyowa Kirin Shares Insights on the Launch of a Virtual Exhibition to Highlight Issues of Rare Disease, X-linked Hypophosphataemia

Shots: Abdul spoke about the launch of a digital exhibition ‘Shine a light’ to raise awareness about rare diseases Abdul also emphasized the significance of this awareness campaign for the patients who were unaware of X-linked Hypophosphataemia(XLH) The interview provides a profound understanding of Kyowa Kirin's initiatives to help patients suffering from XLH Smriti: Can we…
July 27, 2022

Read more

PharmaShots Interview Daphne Chan, Head of Dermatology Medical Affairs at Janssen Shares Insights on Clinical Study in Dermatology
VIEWPOINTS

PharmaShots Interview: Daphne Chan, Head of Dermatology Medical Affairs at Janssen Shares Insights on Clinical Study in Dermatology

Shots: Daphne talked about the P-III study evaluating the safety and efficacy of Tremfya in people of color living with moderate to severe plaque psoriasis Daphne also spoke about how this clinical study will contribute to fill the gaps in care of people who are devoid of treatment due to racial and ethnic variations The…
July 26, 2022

Read more

PharmaShots Interview Kathy Davy, VP of Oncology at Thermo Fisher Scientific Shares Insights on the Real-World Data from Patients with NSCLC at ASCO 2022
VIEWPOINTS

PharmaShots Interview: Kathy Davy, VP of Oncology at Thermo Fisher Scientific Shares Insights on the Real-World Data from Patients with NSCLC at ASCO 2022

Shots: Kathy spoke about the major outcomes from the real-world evidence data presented at the ASCO 2022 Kathy also emphasized on how next-generation sequencing can improve genomic testing The interview gives a view of Thermo Fisher’s vision to bring targeted sequencing that provides faster results for clinicians Smriti: Tell us in detail about the key…
July 20, 2022

Read more

Load more